Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia

Medicine and Dentistry

• Acute Myeloid Leukemia 100%
• Minimal Residual Disease 100%
• Therapeutic Procedure 100%
• Patient 75%
• Diseases 37%
• Transplantation 37%
• Follow up 12%
• Flow Cytometry 12%
• Spontaneous Remission 12%
• Prognostication 12%
• Age Groups 12%
• Laboratory 12%
• Physician 12%
• Chemotherapy 12%

Immunology and Microbiology

• Transplant Procedure 75%
• Real-Time Polymerase Chain Reaction 25%
• Bone Marrow 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Diseases 42%
• Flow Cytometry 14%
• Chemotherapy 14%